Aquestive Therapeutics (AQST) Gains from Investment Securities (2017 - 2018)
Aquestive Therapeutics (AQST) posted quarterly Gains from Investment Securities of $4.1 million for Q3 2018, up 121.41% quarter-over-quarter from $1.9 million in Q2 2018.
Aquestive Therapeutics (AQST) Gains from Investment Securities (2017 - 2018) Analysis & Trends
Aquestive Therapeutics' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $4.1 million for Q3 2018.
- In Q3 2018, Gains from Investment Securities changed N/A year-over-year to $4.1 million; the TTM figure through Jun 2019 stood at $4.1 million (up 108.3% YoY), while the FY2018 annual figure was $5.3 million, up 369.99% from the prior year.
- Gains from Investment Securities for Q3 2018 stood at $4.1 million, up from $1.9 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $4.1 million in Q3 2018, with the low at -$697000.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Aquestive Therapeutics | 560.60 Mn | 560.60 Mn | 9.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 4.12 Mn |
| Sep 30, 2018 | 4.12 Mn |
| Jun 30, 2018 | 1.86 Mn |
| Jun 30, 2018 | 1.86 Mn |
| Mar 31, 2018 | -697,000.00 |
| Mar 31, 2018 | -697,000.00 |
| Dec 31, 2017 | 814,000.00 |
| Dec 31, 2017 | 814,000.00 |
| Jun 30, 2017 | -111,000.00 |
| Jun 30, 2017 | -111,000.00 |